Trove
Sign In Sign Up

Nadeau

Person
Mentions
6
Relationships
0
Events
0
Documents
3
Search

Relationship Network

Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons. Drag nodes to reposition. Node size indicates connection count. Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak). Use legend and help buttons in the graph for more guidance.
No relationships found for this entity.
No events found for this entity.

HOUSE_OVERSIGHT_024903.jpg

This document is page 87 of a 'Cowen Collaborative Insights' report dated February 25, 2019, analyzing the pharmaceutical market for cannabinoid-based drugs, specifically focusing on GW Pharmaceuticals' Epidiolex and its clinical trials for epilepsy. The text details statistical results from Phase III trials, FDA approval timelines, and efficacy comparisons against placebos. The document bears a 'HOUSE_OVERSIGHT_024903' stamp, indicating it was part of a document production for a congressional investigation, and is watermarked for Michael Cella at Cowen.

Financial/pharmaceutical research report (cowen collaborative insights)
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024823.jpg

This document is page 7 of a financial research report titled 'Cowen's Collective View of CBD,' dated February 25, 2019. It outlines the anticipated growth of the U.S. CBD market to $16 billion by 2025 and lists various analysts covering specific sectors such as consumer products, pharmacy, and regulation. The document bears a 'HOUSE_OVERSIGHT' stamp, indicating it was likely produced as part of a congressional investigation, possibly related to banking records, though the text itself contains no direct references to Jeffrey Epstein.

Financial research report / market analysis
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024822.jpg

This document is the Table of Contents for a 'Cowen Collaborative Insights' research report dated February 25, 2019, focusing on the CBD and Cannabis market. The report covers various sectors including consumer products, healthcare, and global landscapes, with sections attributed to specific analysts (e.g., Azer, Nadeau, Schenkel). The document bears a 'HOUSE_OVERSIGHT_024822' Bates stamp, indicating it is part of a document production to the House Oversight Committee, likely related to investigations into financial records.

Financial research report (table of contents)
2025-11-19
Analysis Source
Total Received
$0.00
0 transactions
Total Paid
$0.00
0 transactions
Net Flow
$0.00
0 total transactions
No financial transactions found for this entity. Entity linking may need to be improved.
As Sender
0
As Recipient
0
Total
0
No communications found for this entity. Entity linking may need to be improved.

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein entity

Back to Search